SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The impact of individual donation NAT screening on blood safety – the South African experience
9 references·0 citing·26 second hop
The impact of individual donation NAT screening on blood safety – the South African experience (2006)The impact of individual donation NAT scr…Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa (2006)Prevalence of HIV-1 in Blood …Blood Safety—At What Cost? (2006)Blood Safety—At What Cost?Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Assessing the impact of HBV N…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Human immunodeficiency virus‐1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing (2003)Human immunodeficiency virus‐…Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT (2002)Mathematic modeling of the ri…International application of the Incidence Rate/Window Period model (2002)International application of …The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)The incidence/window period m…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Effect of a National Disaster on Blood Supply and Safety (2003)Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period (2000)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)BLOOD DONORS AND BLOOD COLLECTION: Web interface–supported transmission risk assessment and cost‐effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands (2009)Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screening (2010)Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors (2011)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Prevalence of human immunodeficiency virus, syphilis, hepatitis B and C in blood donations in Namibia (2014)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Ethical and deontological issues in Transfusion Medicine. (2013)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 1997The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection168 cited
  • 2002International application of the Incidence Rate/Window Period model150 cited
  • 2002Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT117 cited
  • 2006Assessing the impact of HBV NAT on window period reduction and residual risk114 cited
  • 2006Prevalence of HIV-1 in Blood Donations Following Implementation of a Structured Blood Safety Policy in South Africa63 cited
  • 2003Human immunodeficiency virus‐1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing47 cited
  • 2006Blood Safety—At What Cost?18 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work